Pediatric Neurology
Volume 46, Issue 2 , Pages 63-69 , February 2012

Role of Cochrane Reviews in Pediatric Neurology

  • Wolfgang Girisch, MS

      Affiliations

    • Medical School, University of Saarland, Homburg, Germany
    • Both authors contributed equally to this work.
  • ,
  • Christiane Willhelm, MS

      Affiliations

    • Medical School, University of Saarland, Homburg, Germany
  • ,
  • Sven Gottschling, MD, PhD

      Affiliations

    • Department of Pain Medicine and Palliative Care, University Children’s Hospital of Saarland, Homburg, Germany
  • ,
  • Ludwig Gortner, MD

      Affiliations

    • Medical School, University of Saarland, Homburg, Germany
    • Department of Pediatrics and Neonatology, University Children’s Hospital of Saarland, Homburg, Germany
  • ,
  • Sascha Meyer, MD, PhD

      Affiliations

    • Department of Pediatrics and Neonatology, University Children’s Hospital of Saarland, Homburg, Germany
    • Department of Neuropediatrics, University Children’s Hospital of Saarland, Homburg, Germany
    • Corresponding Author InformationCommunications should be addressed to: Dr. Meyer; Department of Pediatrics and Neonatology; University Children’s Hospital of Saarland; Building 9; 66421 Homburg, Germany.
    • Both authors contributed equally to this work.

Received 20 September 2011 ,Accepted 28 November 2011.

References 

  1. Dammann O. Evidence-based child neurology. Dev Med Child Neurol. 2006;48:624
  2. Procopis PG. Evidence-based medicine. Dev Med Child Neurol. 2002;44:435
  3. Caplin DA, Rao JK, Filloux F, Bale JF, Van Orman C. Development of performance indicators for the primary care management of pediatric epilepsy: Expert consensus recommendations based on the available evidence. Epilepsia. 2011;47:2011–2019
  4. Upshur RE. Looking for rules in a world of exceptions: Reflections on evidence-based practice. Perspect Biol Med. 2005;48:477–489
  5. Isaacs D, Fitzgerald D. Seven alternatives to evidence based medicine. Br Med J [Clin Res]. 1999;319:1618
  6. Clinicians for the Restoration of Autonomous Practice (CRAP) Writing Group. EBM: Unmasking the ugly truth. Br Med J [Clin Res]. 2002;325:1496–1498
  7. Caplan LR. How well does “evidence-based” medicine help neurologists care for individual patients?. Rev Neurol Dis. 2007;4:75–84
  8. Meyer S, Gottschling S, Gortner L. Evidence-based medicine in neonatology: Time to re-think. Eur J Pediatr. 2008;167:1089
  9. Yalçin B, Kremer LCM, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2010;5:CD006301
  10. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database Syst Rev. 2000;3:CD001030
  11. Michael B, Marson AG. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev. 2008;2:CD004154
  12. Marson AG, Kadir ZZ, Hutton JL, Chadwick DW. Gabapentin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 1999;1:CD001415
  13. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2001;3:CD001909
  14. Castillo SM, Schmidt DB, White S, Shukralla A. Oxcarbazepine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2000;3:CD002028
  15. Taylor S, Tudur Smith C, Williamson PR, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev. 2003;2:CD002217
  16. Lozsadi D, Hemming K, Marson AG. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2008;1:CD005612
  17. Pereira J, Marson AG, Hutton JL. Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syste Rev. 2002;3:CD001908
  18. Jette N, Hemming K, Hutton JL, Marson AG. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2008;3:CD001417
  19. Hemming K, Maguire MJ, Hutton JL, Marson AG. Vigabatrin for refractory partial epilepsy. Cochrane Database Syst Rev. 2008;3:CD007302
  20. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2005;4:CD001416
  21. Beavis J, Kerr M, Marson AG, Dojcinov I. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev. 2007;3:CD005399
  22. Privitera MD, Welty TTE, Ficker DDM, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Systc Rev. 2002;1:CD002896
  23. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2005;4:CD003723
  24. Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008;3:CD001905
  25. Sirven J, Sperling MR, Wingerchuk DM. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2001;3:CD001902
  26. Thompson DC, Rivara F, Thompson R. Helmets for preventing head and facial injuries in bicyclists. Cochrane Database Syst Rev. 1999;4:CD001855
  27. Liu BC, Ivers R, Norton R, Boufous S, Blows S, Lo SK. Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev. 2008;1:CD004333
  28. Soo C, Tate R. Psychological treatment for anxiety in people with traumatic brain injury. Cochrane Database Syst Rev. 2007;3:CD005239
  29. Brønfort G, Nilsson N, Haas M, Evans RL, Goldsmith CH, Assendelft WJJ, et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev. 2004;3:CD001878
  30. Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst Rev. 2010;1:CD003469
  31. Hoare BJ, Wasiak J, Imms C, Carey L. Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst Rev. 2007;2:CD004149
  32. Costa J, Espírito-Santo CC, Borges AA, Ferreira J, Coelho MM, Moore P, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2005;1:CD003633
  33. Pringsheim T, Marras C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev. 2009;2:CD006996
  34. Manzur AY, Kuntzer T, Pike M, Swan AV. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008;1:CD003725
  35. Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev. 2011;2:CD004760
  36. Annane D, Orlikowski D, Chevret S, Chevrolet JC, Raphaël JC. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev. 2007;4:CD001941
  37. Salinas RA, Alvarez G, Daly F, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2010;3:CD001942
  38. Mehndiratta MM, Hughes RAC, Agarwal P. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2004;3:CD003906
  39. Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2002;2:CD001798
  40. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2002;2:CD001046
  41. van der Schaaf I, Algra A, Wermer M, et al. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;4:CD003085
  42. Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev. 2004;3:CD004848
  43. Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev. 2006;1:CD001031
  44. Hancock EC, Cross HJ. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2009;3:CD003277
  45. Sahuquillo J. Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic brain injury. Cochrane Database Syst Rev. 2006;1:CD003983
  46. Bennett MH, Trytko B, Jonker B. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Cochrane Database Syst Rev. 2004;4:CD004609
  47. Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev. 2005;2:CD002828
  48. Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database Syst Rev. 2007;4:CD005224
  49. Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2010;6:CD002063
  50. Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev. 2009;3:CD003908
  51. Prasad K, Mendelow AD, Gregson B. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev. 2008;4:CD000200
  52. Dorhout Mees S, Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3:CD000277
  53. McGuire W, Fowlie PW, Soll RF. What has the Cochrane Collaboration ever done for newborn infants?. Arch Dis Child Fetal Neonatal Ed. 2010;95:F2–F6
  54. Dodd JM, Crowther CA. Cochrane reviews in pregnancy: The role of perinatal randomized trials and systematic reviews in establishing evidence. Semin Fetal Neonatal Med. 2006;11:97–103
  55. Askie LM, Henderson-Smart DJ. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;4:CD00107
  56. Schmidt B, Roberts RS, Davis P, et al. Caffeine for Apnea of Prematurity Trial Group: Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893–1902
  57. Mastriani KS, Williams VC, Hulsey TC, Wheless JW, Maria BL. Evidence-based versus reported epilepsy management practices. J Child Neurol. 2008;23:507–514
  58. Bassan H, Bental Y, Shany E, Berger I, Froom P, Levi L, et al. Neonatal seizure: Dilemmas in workup and management. Pediatr Neurol. 2008;38:415–421

PII: S0887-8994(11)00508-X

doi: 10.1016/j.pediatrneurol.2011.11.021

Pediatric Neurology
Volume 46, Issue 2 , Pages 63-69 , February 2012